Robotic bronchoscopic ablation for small peripheral lung tumors

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This single-center observational registry at M.D. Anderson collects clinical, procedural, radiographic, and outcomes data from participants with known lung cancer or lung metastases who undergo robotic-assisted bronchoscopic ablation of peripheral tumors. It aggregates intra-operative, peri-operative, and long-term safety outcomes including bleeding, pneumothorax, and infection, and tracks oncologic outcomes such as local tumor progression by RECIST, LTPFS, PFS, DSS, and OS. The registry also analyzes serial imaging to characterize radiographic evolution of ablated lesions and evaluates tumor- and patient-level risk factors associated with safety and oncologic results. Procedures in which bronchoscopic ablation was planned but aborted for technical reasons are excluded from analysis.

Why it matters

Who can join: the full rules

Inclusion Criteria:

Patients with peripheral lung tumors (primary or metastatic) that have been or will be ablated via robotic bronchoscopy.

Exclusion Criteria:

Patients with planned bronchoscopic ablations of peripheral lung tumors that were aborted for technical reasons (ablation was not completed).

Where it's running

• MD Anderson Cancer Center
  Houston, Texas, United States Recruiting

Study contacts

• Principal investigator: Roberto F Casal, MD — Prinicipal Investigator
• Study coordinator: Roberto F Casal, MD
• Email: rfcasal@mdanderson.org
• Phone: (713) 792-6238

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Community- or home-based exercise for adults with weakened heart or lungs

  This test will see if an eight-week, community- or home-based exercise program can improve heart and lung function in adults 18–85 with reduced cardiopulmonary fitness.

  Recruiting Guangdong Provincial People's Hospital · Guangzhou, Guangdong · NCT07154355

• Register of patients with thoracic tumors

  This study is collecting information from patients with lung cancer and other chest tumors to see how different treatments can be tailored to help them feel better and live longer.

  Recruiting at 78 sites Spanish Lung Cancer Group · Ferrol, A Coruña and 78 other locations · NCT02941458

• Preventing heart problems in overweight/obese young sarcoma survivors with tirzepatide

  This feasibility study tests whether tirzepatide can be safely given to overweight or obese young adults (18–39) who have completed doxorubicin for soft tissue or bone sarcoma to see if it’s feasible to use in the first year after therapy.

  Recruiting Phase 2 M.D. Anderson Cancer Center · Houston, Texas · NCT07874828

• Predicting lymphedema risk in inflammatory breast cancer patients using preoperative body impedance analysis

  This study tests whether a preoperative bioimpedance test can help identify IBC patients who are at risk for developing lymphedema.

  Recruiting M.D. Anderson Cancer Center · Houston, Texas · NCT07855627

• Precision genomic testing to guide first-line LBCL treatment readiness

  Doctors will see if a tumor genomic test can help tailor first-line treatment for adults with LBCL by the start of the second cycle of standard therapy.

  Recruiting M.D. Anderson Cancer Center · Houston, Texas · NCT07829445

• Using Apple Vision Pro in image-guided procedures

  This study tests whether the Apple Vision Pro can be used during CT-guided biopsy procedures to help with imaging and guidance.

  Recruiting M.D. Anderson Cancer Center · Houston, Texas · NCT07819513

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.